BIOMARIN PHARMACEUTICAL INC - 8-K Filing
BioMarin discontinues development of VOXZOGO for children with Noonan syndrome on September 15, 2026 (Items: 8.01 Other Events)
Tickers: $BMRN
More Regulatory news
- Future Vision II Acquisition Corp. - 10-Q Filing
- THUNDER MOUNTAIN GOLD INC - 10-Q Filing
- MiNK Therapeutics, Inc. - 8-K Filing
- SusGlobal Energy Corp. - 10-Q Filing
- Ideal Power Inc. - 8-K Filing
- DIGI INTERNATIONAL INC - 8-K Filing
- ZeroStack Corp. - 8-K Filing
- Sound Point Meridian Capital, Inc. - 8-K Filing
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing